Prospective data suggest DecisionDx-Melanoma may help refine SLNB decisions and identify recurrence risk beyond conventional staging.
|Videos|July 24, 2020
The promise of laser-assisted drug delivery
Author(s)Jessica Barry
In this video, Hema Sundaram, MA, MD, FAAD, highlights important safety considerations to keep in mind regarding laser-assisted drug delivery.
Advertisement
During our conversation, Dr. Sundaram emphasized several considerations providers should keep in mind regarding the safety and efficacy of laser-assisted drug delivery.
Browse more topics from Dr. Sundaram’s AAD Virtual Meeting Experience (VMX) presentation:
How does botulinum toxin treat scars? The power of fat grafting Can botulinum toxin benefit rosacea patients?
For more information about AAD VMX,
Questions? Contact Dr. Sundaram by messaging her through Instagram at
Reference
Sundaram H. What's new in aesthetic therapeutics. Therapeutic Hotline Session. AAD VMX 2020; June 12, 2020.
Advertisement
Related to this article
Can “Botox in a bottle” really rival injectable neuromodulators? We examine the evidence behind topical peptide serums and Argireline.
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Approves Pritelivir for Refractory Mucocutaneous HSV in Immunocompromised Adults
2
GLP-1 Agonists Address Metabolic Risk in Psoriatic Disease
3
EB06 Phase 2 Vitiligo Study Receives FDA IND Clearance
4
EADV 2026 Atopic Dermatitis Highlights: Tilrekimig, RAC2 Inhibition, and Level Up Data
5